John P. Longenecker Ph.D., Director at Pacira BioSciences, Inc. (PCRX), sold 5,000 shares at $72.26 ($361K) on 2021-03-01, disclosed to the SEC on 2021-03-03.
Open-market sale of $361k PCRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ALRN | BUY | 2018-08-14 | $25K | — | Filing → |
| PCRX | BUY | 2016-01-14 | $20K | — | Filing → |
| PCRX | SELL | 2015-03-16 | $286K | — | Filing → |